News

Oxford Uni and Oracle join forces on COVID analysis system

The Pathogen Pipeline Platform will use Oracle's cloud infrastructure to inform governments about new strains of the virus

Oxford University and Oracle have collaborated on a Global Pathogen Analysis System to help governments identify and act on the spread of new COVID variants. 

The system combines Oxford University's Scalable Pathogen Pipeline Platform, which was first used for tuberculosis, to with the Oracle Cloud Infrastructure to analyse and compare sequence data for COVID. The university has already processed half of the world's COVID sequences, which is more than 500,000 in total.

The Pathogen Pipeline is available worldwide, 24-hours a day in the Oracle Cloud and its processing capability has been enhanced with extensive new development work from Oracle that enables high performance and security. 

The system will use Oracle's machine learning services to deliver comprehensive results within minutes of submission before sharing its findings with countries around the world in a secure environment. This includes identifying variants of interest and their potential impact on vaccine and treatment effectiveness. There will be an analytics dashboard to show which specific strains spread more quickly and whether certain genetic features contribute to its increased transmissibility and vaccine tolerance.  

"This powerful new tool will enable public health scientists in research establishments, public health agencies, healthcare services, and diagnostic companies around the world to help further understanding of infectious diseases, starting with the coronavirus," said Derrick Crook, professor of microbiology in the Nuffield Department of Medicine at the University of Oxford.

Related Resource

What’s next for the education sector?

A new learning experience

White text against a black background reading "UCISA A new learning experience: what's next for the education sector? Download now

"The Global Pathogen Analysis System will help to establish a global common standard for assembling and analysing this new virus, as well as other microbial threats to public health. This adds a new dimension in our ability to process pathogen data. We are excited to partner with Oracle to further our research using this cutting-edge technology platform."

The platform will be free for researchers and non-profits to use worldwide and the next steps will be extending the service to more pathogens beyond the COVID pandemic to enable governments to act on future outbreaks quickly. 

Featured Resources

How to choose an AI vendor

Five key things to look for in an AI vendor

Download now

The UK 2020 Databerg report

Cloud adoption trends in the UK and recommendations for cloud migration

Download now

2021 state of email security report: Ransomware on the rise

Securing the enterprise in the COVID world

Download now

The impact of AWS in the UK

How AWS is powering Britain's fastest-growing companies

Download now

Recommended

Demystify Azure migration
Whitepaper

Demystify Azure migration

18 Jun 2021
On-premises vs cloud: Which is better for your business?
cloud computing

On-premises vs cloud: Which is better for your business?

16 Jun 2021
VMware and Vapor IO to develop Multi-Cloud Services Grid
cloud computing

VMware and Vapor IO to develop Multi-Cloud Services Grid

10 Jun 2021
Most CISOs worry cloud software flaws aren’t being caught
cloud security

Most CISOs worry cloud software flaws aren’t being caught

7 Jun 2021

Most Popular

Q&A: Enabling transformation
Sponsored

Q&A: Enabling transformation

10 Jun 2021
OnePlus 9 Pro review: An instant cult classic
Hardware

OnePlus 9 Pro review: An instant cult classic

7 Jun 2021
Ten-year-old iOS 4 recreated as an iPhone app
iOS

Ten-year-old iOS 4 recreated as an iPhone app

10 Jun 2021